Jiuzhou Pharma
60345614.380.00% ( 0.00 )
Jiuzhou Pharma (603456)
Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The compan...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 14.38
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 22.15
- Volume Ratio
- 0.00
- Turnover Ratio
- --
Jiuzhou Pharma Analyst Rating
View MoreForecast & Rating
Jun 23, 2026Price forecast
¥20.9145.39%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
News
- Zhitong · Oct 29, 2025 at 12:15 AM
The innovative drug concept surged in the afternoon, with Nossan hitting the 20% limit up, followed by gains in PR, Tigermed, Jiuzhou Pharma, and Highfine
- Zhitong · Oct 15, 2025 at 03:36 AM
Jiuzhou Pharma released its performance for the first three quarters, with a net profit attributable to the parent company of 748 million yuan, a year-on-year increase of 18.51%
- Zhitong · Sep 24, 2025 at 08:55 PM
CRO concept stocks fluctuate and rise, Jiuzhou Pharma hits the limit up
- Zhitong · Aug 12, 2025 at 02:41 AM
Jiuzhou Pharma's subsidiary Ruibo Suzhou passes on-site inspection by the U.S. FDA
- Zhitong · Aug 8, 2025 at 01:37 AM
Cinda Securities: Jiuzhou Pharma's DMO business maintains high growth, and the layout of new molecular business is expected to create new growth points
- Zhitong · Aug 6, 2025 at 07:33 PM
28 stocks received buy ratings from brokerages, with Jiuzhou Pharma's target increase reaching 57.75%
